A randomized, single dose, cross-over, replicated, open-label bioequivalence study comparing indacaterol/glycopyrronium (85/43mcg inhalation powder hard capsules) (PG341 [Celon Pharma] vs Ultibro Breezhaler [Novartis])

2024-514725-38-00 Protocol 01INDA2024 Human pharmacology (Phase I) - Bioequivalence study Ended

Start 26 May 2025 · End 1 Sep 2025 · Status Ended · 1 EU/EEA countries · 1 sites · Protocol 01INDA2024

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Bioequivalence study
Status Ended
Participants planned 40
Countries 1
Sites 1

Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)

Key facts

Sponsor
Celon Pharma S.A.
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Respiratory Tract Diseases [C08]
Trial duration
26 May 2025 → 1 Sep 2025
Decision date (initial)
2024-11-18
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)

VersionLevelCodeTermSystem organ class
26.1 PT 10009033 Chronic obstructive pulmonary disease 100000004855

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Celon Pharma S.A.

Sponsor organisation
Celon Pharma S.A.
Address
Ul. Ogrodowa 2a, Kielpin Kielpin
City
Lomianki
Postcode
05-092
Country
Poland

Scientific contact point

Organisation
Celon Pharma S.A.
Contact name
Clinical trial information point

Public contact point

Organisation
Celon Pharma S.A.
Contact name
Clinical trial information point

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Poland Ended 40 1
Rest of world 0

Investigational sites

Poland

1 site · Ended
Bioresearch Group Sp. z o.o.
BioResearch Group, Ul. Sokolowska 9/u2, 01-142, Warsaw

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Poland 2025-05-26 2025-09-01 2025-06-01

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-08-07 Poland Acceptable
2024-11-12
2024-11-18
2 NON SUBSTANTIAL MODIFICATION NSM-1 2025-09-15 Poland Acceptable
2024-11-12
2025-09-15